Drug
Rmc 5127
Rmc 5127: highest development phase Phase 1, developed by Revolution Medicines. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Revolution Medicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| RMC-5127 NCT07349537 | Phase 1 | Non-small Cell Lung Cancer (NSCLC) |
Latest
No recent events.
Follow Rmc 5127 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.